CN104997946A - Application of traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis - Google Patents
Application of traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis Download PDFInfo
- Publication number
- CN104997946A CN104997946A CN201510540187.9A CN201510540187A CN104997946A CN 104997946 A CN104997946 A CN 104997946A CN 201510540187 A CN201510540187 A CN 201510540187A CN 104997946 A CN104997946 A CN 104997946A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses application of a traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis. The medicine composition comprises the following ingredients of effective preparation components in parts by weight: 58 to 82 parts of gmelin sealavender herb, 55 to 79 parts of singharanut fruit-pedicel, 50 to 74 parts of patience dock root, 48 to 72 parts of callicarpa bodinieri, 45 to 65 parts of japan clover herb, 45 to 65 parts of common bombax root, 40 to 60 parts of buckbean, 35 to 55 parts of himalayan eriosema root, 35 to 55 parts of iron holly bark, 30 to 50 parts of cassiabarktree fruit, 28 to 48 parts of rock cotoneaster leaves, 28 to 48 parts of dalbergia wood, 20 to 40 parts of ageratum, 15 to 35 parts of quince, 10 to 30 parts of limestone powder and 5 to 25 parts of wild ginger. The invention aims at providing a novel treatment purpose of the traditional Chinese medicine composition, the clinical application range is expanded, and the waste of good medicine resources is avoided.
Description
Technical field
The present invention relates to field of medicaments, the specifically application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine.
Background technology
Tonsillitis can be divided into acute tonsillitis and chronic tonsillitis.After suffering from acute infectious disease (as scarlet fever, measles, influenza, diphtheria etc.), can cause chronic tonsillitis, nasal cavity has sinus infection also can to occur together primary disease.The obvious enlargement of tonsil, general congested and a large amount of neutrophil infiltration, is full of purulent exudate in crypts.Pathogen majority is Hemolytic streptococcus, is secondly hemophilus influenza, streptococcus pneumoniae, staphylococcus etc.Often onset is anxious, pharyngalgia is obvious, having a medical check-up with high heat (body temperature can reach more than 39 DEG C) to find antiadoncus, hyperemia, there is yellow purulent secretion on surface, especially child Ke Yingao heat and twitch, vomit or lethargy, inappetence, constipation and systemic pain etc.Sometimes with submandibular lymph nodes enlargement, tenderness, the absence of signs and pulmonary haves a medical check-up.General Symptoms: onset urgency, aversion to cold, high heat, can reach 39 ~ 40 DEG C, dizzy, headache and whole body aching and tired, especially child Ke Yingao heat and twitch, vomit or lethargy, inappetence, constipation etc.Local symptom: pharyngalgia is obvious, and when swallowing more so, violent person can be radiated to ear, xerostomia.Badly influence the healthy living of juvenile.
At present, be main to the treatment of this disease mainly with anti-inflammation, mostly be penicillin and erythromycin, but along with the development of society and antibiotic abuse, clinical observation finds that this type of infant is many and produces drug resistance, and therefore simple treatment is difficult to reach ideal effect and easily recurs.Also excision can be carried out, but the immune organ that tonsil is body weight for humans to be wanted, there is the function of cellular immunization and humoral immunization, the antibody I gA immunocompetence produced is strong, can anti-bacteria in the adhesion of respiratory mucosa, growth and diffusion, have neutralization to virus and suppress diffusion, its immunity is the most active in children's's phase (3 ~ 5 years old), removal of tonsils will eliminate the immunoreation of local, reduces the resistance of respiratory tract.
Prescription of the present invention is after on March 4th, 2015 is open as the medicine for the treatment of gastric ulcer in the application of Chinese patent 201410758752.4, we find that in a large amount of clinical practice the party is except curing mainly function, also there is the good efficacy for the treatment of viral influenza, not only onset is rapid, curative effect lasting, and untoward reaction is few.In order to develop the new clinical application of this medicine further, reducing the wasting of resources of medicine, this medicine having been carried out a series of drug effect and dosage form research, for clinical practice is taken a firm foundation widely.
Summary of the invention
The object of the present invention is to provide a kind of novelty teabag of Chinese medicine composition, the specifically application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine.
For achieving the above object, the invention provides following technical scheme:
The application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 58-82 part, Calyx Trapae 55-79 part, Radix Rumicis Patientiae 50-74 part, Folium Callicarpae Formosanae 48-72 part, Herba Kummerowiae Striatae 45-65 part, Radix Gossampini 45-65 part, Herba menyanthis 40-60 part, Eriosema himalaicum Ohashi 35-55 part, Cortex Ilicis Rotundae 35-55 part, Fructus cinnamomi immaturus 30-50 part, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 28-48 part, Lignum Dalbergiae Odoriferae 28-48 part, Herba Pogostemonis 20-40 Fen, Fructus cydoniae oblongae 15-35 part, Chalk 10-30 part and Herba Asari Forbesii 5-25 part.Chinese medicine composition of the present invention has the effects such as promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion, tranquilizing by nourishing the heart, promoting blood circulation and hemostasis, clinical only for the treatment to gastric ulcer at present.
As the further scheme of the present invention: according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 76 parts, Calyx Trapae 73 parts, Radix Rumicis Patientiae 68 parts, Folium Callicarpae Formosanae 66 parts, Herba Kummerowiae Striatae 60 parts, Radix Gossampini 60 parts, Herba menyanthis 55 parts, Eriosema himalaicum Ohashi 50 parts, Cortex Ilicis Rotundae 50 parts, Fructus cinnamomi immaturus 45 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 43 parts, Lignum Dalbergiae Odoriferae 43 parts, Herba Pogostemonis 35 Fen, Fructus cydoniae oblongae 30 parts, Chalk 25 parts and Herba Asari Forbesii 20 parts.
As the further scheme of the present invention: according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 70 parts, Calyx Trapae 67 parts, Radix Rumicis Patientiae 62 parts, Folium Callicarpae Formosanae 60 parts, Herba Kummerowiae Striatae 55 parts, Radix Gossampini 55 parts, Herba menyanthis 50 parts, Eriosema himalaicum Ohashi 45 parts, Cortex Ilicis Rotundae 45 parts, Fructus cinnamomi immaturus 40 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 38 parts, Lignum Dalbergiae Odoriferae 38 parts, Herba Pogostemonis 30 Fen, Fructus cydoniae oblongae 25 parts, Chalk 20 parts and Herba Asari Forbesii 15 parts.
As the further scheme of the present invention: according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 64 parts, Calyx Trapae 61 parts, Radix Rumicis Patientiae 56 parts, Folium Callicarpae Formosanae 54 parts, Herba Kummerowiae Striatae 50 parts, Radix Gossampini 50 parts, Herba menyanthis 45 parts, Eriosema himalaicum Ohashi 40 parts, Cortex Ilicis Rotundae 40 parts, Fructus cinnamomi immaturus 35 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 33 parts, Lignum Dalbergiae Odoriferae 33 parts, Herba Pogostemonis 25 Fen, Fructus cydoniae oblongae 20 parts, Chalk 15 parts and Herba Asari Forbesii 10 parts.
The preparation method of described Chinese medicine composition, comprises the following steps:
(1) by Herba Limonii Gmelinii, Calyx Trapae, Radix Rumicis Patientiae, Radix Gossampini, Cortex Ilicis Rotundae, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis), Herba Pogostemonis with Fructus cydoniae oblongae puts into container, first add 10-15 times amount distilled water immersion after 4-5 hour, heated and boiled 3-4 hour, extract; Second time adds 8-10 times amount distilled water heated and boiled 2-3 hour, extracts; Third time adds 6-8 times amount distilled water heated and boiled 1-2 hour, extracts; Merge extractive liquid, filters, obtains filtrate for subsequent use;
(2) Folium Callicarpae Formosanae, Fructus cinnamomi immaturus, Lignum Dalbergiae Odoriferae and Chalk are ground into powder, cross 100 order fine powders, for subsequent use;
(3) Herba Kummerowiae Striatae and Herba menyanthis are smash juice, filter impurity, stays juice, for subsequent use;
(4) Eriosema himalaicum Ohashi and Herba Asari Forbesii are immersed yellow wine 3-4 hour, after taking-up, sun dehydration, pours in pot, and slow fire parch, after cooling, is smashed to pieces and ground into powder, crosses 120 order fine powders, for subsequent use;
(5) by the juice mixing obtained by fine powder obtained to filtrate obtained for above-mentioned steps (1), step (2) and step (4) and step (3), to obtain final product.
The preparation method of Chinese medicine composition of the present invention is suitable for commercial Application.Described Chinese medicine composition comprises the various oral formulations be pharmaceutically suitable for, such as granule, capsule, tablet.The method that the present invention prepares various oral formulations is pharmaceutically common method, as Conventional compression, granulation, encapsulated etc.Instructions of taking: oral, every day, potion, point morning, evening twice, each containing crude drug amount 100-125g.
The present invention finds that in a large amount of clinical practices it has the effect of significant treatment pediatric amygdalitis, and therefore, we have carried out more deep research to the novelty teabag that the present invention treats pediatric amygdalitis, and existing by main effect experiment, details are as follows:
Clinical data
200 examples are selected, 3 ~ 12 years old age, 5 years old mean age from outpatient service tonsillitis, wherein, male 100 example, women 100 example; Be divided into treatment group and matched group at random by medical priority, often organize 100 examples.The age of two groups of infants, the no significant difference of severity extent.All cases are all by the diagnostic criteria of " paediatric internal medicine ".All infants all have an anxious high heat, have sore throat, Annual wool yield tells extremities aching pain, headache, part child has uneasiness of crying and screaming, refusing to eat, vomiting, look into the congested enlargement I ~ III degree of tonsil, yellow point-like secretions is seen on surface, generates heat 1 ~ 5 day, average 2.5 days, auxillary temperature 39 ~ 41.7 ° of C, without other medical history and symptom, before treatment, hepatic and renal function is all normal.
Matched group injection azithromycin 10mg every day, 3 days courses for the treatment of, according to circumstances continues oral azithromycin after drug withdrawal; The water decoction of the oral medicine of the present invention for the treatment of group, potion on the one, sooner or later respectively once.
In therapeutic process, the symptom of observed and recorded infant and sign, make regular check on routine blood test, Liver and kidney function, record untoward reaction, remedy measures and lapsing to.
Criterion of therapeutical effect:
Cure: pharyngalgia, heating paresthesia disappear, body temperature is normal, and tonsil checks no pus point, without congested;
Effective: pharyngalgia and pharyngeal symptom obviously alleviate, dense elimination on tonsil, but sign, disease, routine blood test do not recover normal completely;
Effective: pharyngalgia and pharyngeal symptom obviously alleviate, on tonsil, dense point alleviates, and sign, disease, routine blood test do not recover normal;
Invalid: bottleneck throat symptom is without significant change.
Therapeutic outcome: patient treatment is observe the curative effect after 7 days, treatment group 100 example, wherein effective 92 examples (92%), 8 examples that take a turn for the better (8%), invalid 0 example (0%), total effective rate 100%; Matched group 100 example, wherein effective 65 examples (65%), 26 examples that take a turn for the better (26%), no effect 9 (9%), total effective rate 91%.Two groups of total effective rate comparing differences have significant (P < 0.05), and treatment group therapeutic effect is obviously better than matched group.
Untoward reaction: in treatment group, slight symptom of digestive tract appears in 15 examples, as felt sick, suffering from abdominal pain; In matched group there is the significantly symptom such as nauseating, drowsiness in 49 examples, the diarrhoea that wherein 10 example appearance are heavier, vomiting.The difference having significance is contrasted with treatment group.Two groups are all damaged without obvious Liver and kidney function.
Compared with prior art, the invention has the beneficial effects as follows:
1, this traditional Chinese medicine composition for treating pediatric amygdalitis has no side effect, and it is low to have price, is easy to by advantages such as patient accept;
2, this Chinese medicine composition abundant raw materials, preparation technology is simple, environmentally friendly, has good application prospect at treatment pediatric amygdalitis;
3, invention increases the clinical application range of this Chinese medicine composition, effectively avoid the waste of good drug resource.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, the application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 82 parts, Calyx Trapae 79 parts, Radix Rumicis Patientiae 74 parts, Folium Callicarpae Formosanae 72 parts, Herba Kummerowiae Striatae 65 parts, Radix Gossampini 65 parts, Herba menyanthis 60 parts, Eriosema himalaicum Ohashi 55 parts, Cortex Ilicis Rotundae 55 parts, Fructus cinnamomi immaturus 50 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 48 parts, Lignum Dalbergiae Odoriferae 48 parts, Herba Pogostemonis 40 Fen, Fructus cydoniae oblongae 35 parts, Chalk 30 parts and Herba Asari Forbesii 25 parts.
The preparation method of described Chinese medicine composition, comprises the following steps:
(1) by Herba Limonii Gmelinii, Calyx Trapae, Radix Rumicis Patientiae, Radix Gossampini, Cortex Ilicis Rotundae, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis), Herba Pogostemonis with Fructus cydoniae oblongae puts into container, first add 15 times amount distilled water immersions after 5 hours, heated and boiled 4 hours, extract; Second time adds 10 times amount distilled water heated and boiled 3 hours, extracts; Third time adds 8 times amount distilled water heated and boiled 2 hours, extracts; Merge extractive liquid, filters, obtains filtrate for subsequent use;
(2) Folium Callicarpae Formosanae, Fructus cinnamomi immaturus, Lignum Dalbergiae Odoriferae and Chalk are ground into powder, cross 100 order fine powders, for subsequent use;
(3) Herba Kummerowiae Striatae and Herba menyanthis are smash juice, filter impurity, stays juice, for subsequent use;
(4) Eriosema himalaicum Ohashi and Herba Asari Forbesii are immersed yellow wine 4 hours, after taking-up, sun dehydration, pours in pot, and slow fire parch, after cooling, is smashed to pieces and ground into powder, crosses 120 order fine powders, for subsequent use;
(5) by the juice mixing obtained by fine powder obtained to filtrate obtained for above-mentioned steps (1), step (2) and step (4) and step (3), to obtain final product.
Embodiment 2
In the embodiment of the present invention, the application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 76 parts, Calyx Trapae 73 parts, Radix Rumicis Patientiae 68 parts, Folium Callicarpae Formosanae 66 parts, Herba Kummerowiae Striatae 60 parts, Radix Gossampini 60 parts, Herba menyanthis 55 parts, Eriosema himalaicum Ohashi 50 parts, Cortex Ilicis Rotundae 50 parts, Fructus cinnamomi immaturus 45 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 43 parts, Lignum Dalbergiae Odoriferae 43 parts, Herba Pogostemonis 35 Fen, Fructus cydoniae oblongae 30 parts, Chalk 25 parts and Herba Asari Forbesii 20 parts.
The preparation method of described Chinese medicine composition, comprises the following steps:
(1) by Herba Limonii Gmelinii, Calyx Trapae, Radix Rumicis Patientiae, Radix Gossampini, Cortex Ilicis Rotundae, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis), Herba Pogostemonis with Fructus cydoniae oblongae puts into container, first add 10 times amount distilled water immersions after 4 hours, heated and boiled 3 hours, extract; Second time adds 8 times amount distilled water heated and boiled 2 hours, extracts; Third time adds 6 times amount distilled water heated and boiled 1 hour, extracts; Merge extractive liquid, filters, obtains filtrate for subsequent use;
(2) Folium Callicarpae Formosanae, Fructus cinnamomi immaturus, Lignum Dalbergiae Odoriferae and Chalk are ground into powder, cross 100 order fine powders, for subsequent use;
(3) Herba Kummerowiae Striatae and Herba menyanthis are smash juice, filter impurity, stays juice, for subsequent use;
(4) Eriosema himalaicum Ohashi and Herba Asari Forbesii are immersed yellow wine 3 hours, after taking-up, sun dehydration, pours in pot, and slow fire parch, after cooling, is smashed to pieces and ground into powder, crosses 120 order fine powders, for subsequent use;
(5) by the juice mixing obtained by fine powder obtained to filtrate obtained for above-mentioned steps (1), step (2) and step (4) and step (3), to obtain final product.
Embodiment 3
In the embodiment of the present invention, the application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 70 parts, Calyx Trapae 67 parts, Radix Rumicis Patientiae 62 parts, Folium Callicarpae Formosanae 60 parts, Herba Kummerowiae Striatae 55 parts, Radix Gossampini 55 parts, Herba menyanthis 50 parts, Eriosema himalaicum Ohashi 45 parts, Cortex Ilicis Rotundae 45 parts, Fructus cinnamomi immaturus 40 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 38 parts, Lignum Dalbergiae Odoriferae 38 parts, Herba Pogostemonis 30 Fen, Fructus cydoniae oblongae 25 parts, Chalk 20 parts and Herba Asari Forbesii 15 parts.
The preparation method of described Chinese medicine composition, comprises the following steps:
(1) by Herba Limonii Gmelinii, Calyx Trapae, Radix Rumicis Patientiae, Radix Gossampini, Cortex Ilicis Rotundae, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis), Herba Pogostemonis with Fructus cydoniae oblongae puts into container, first add 10 times amount distilled water immersions after 5 hours, heated and boiled 4 hours, extract; Second time adds 8 times amount distilled water heated and boiled 3 hours, extracts; Third time adds 6 times amount distilled water heated and boiled 2 hours, extracts; Merge extractive liquid, filters, obtains filtrate for subsequent use;
(2) Folium Callicarpae Formosanae, Fructus cinnamomi immaturus, Lignum Dalbergiae Odoriferae and Chalk are ground into powder, cross 100 order fine powders, for subsequent use;
(3) Herba Kummerowiae Striatae and Herba menyanthis are smash juice, filter impurity, stays juice, for subsequent use;
(4) Eriosema himalaicum Ohashi and Herba Asari Forbesii are immersed yellow wine 3 hours, after taking-up, sun dehydration, pours in pot, and slow fire parch, after cooling, is smashed to pieces and ground into powder, crosses 120 order fine powders, for subsequent use;
(5) by the juice mixing obtained by fine powder obtained to filtrate obtained for above-mentioned steps (1), step (2) and step (4) and step (3), to obtain final product.
Embodiment 4
In the embodiment of the present invention, the application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 64 parts, Calyx Trapae 61 parts, Radix Rumicis Patientiae 56 parts, Folium Callicarpae Formosanae 54 parts, Herba Kummerowiae Striatae 50 parts, Radix Gossampini 50 parts, Herba menyanthis 45 parts, Eriosema himalaicum Ohashi 40 parts, Cortex Ilicis Rotundae 40 parts, Fructus cinnamomi immaturus 35 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 33 parts, Lignum Dalbergiae Odoriferae 33 parts, Herba Pogostemonis 25 Fen, Fructus cydoniae oblongae 20 parts, Chalk 15 parts and Herba Asari Forbesii 10 parts.
The preparation method of described Chinese medicine composition, comprises the following steps:
(1) by Herba Limonii Gmelinii, Calyx Trapae, Radix Rumicis Patientiae, Radix Gossampini, Cortex Ilicis Rotundae, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis), Herba Pogostemonis with Fructus cydoniae oblongae puts into container, first add 15 times amount distilled water immersions after 4 hours, heated and boiled 4 hours, extract; Second time adds 8 times amount distilled water heated and boiled 3 hours, extracts; Third time adds 6 times amount distilled water heated and boiled 1 hour, extracts; Merge extractive liquid, filters, obtains filtrate for subsequent use;
(2) Folium Callicarpae Formosanae, Fructus cinnamomi immaturus, Lignum Dalbergiae Odoriferae and Chalk are ground into powder, cross 100 order fine powders, for subsequent use;
(3) Herba Kummerowiae Striatae and Herba menyanthis are smash juice, filter impurity, stays juice, for subsequent use;
(4) Eriosema himalaicum Ohashi and Herba Asari Forbesii are immersed yellow wine 4 hours, after taking-up, sun dehydration, pours in pot, and slow fire parch, after cooling, is smashed to pieces and ground into powder, crosses 120 order fine powders, for subsequent use;
(5) by the juice mixing obtained by fine powder obtained to filtrate obtained for above-mentioned steps (1), step (2) and step (4) and step (3), to obtain final product.
Embodiment 5
In the embodiment of the present invention, the application of a kind of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 58 parts, Calyx Trapae 55 parts, Radix Rumicis Patientiae 50 parts, Folium Callicarpae Formosanae 48 parts, Herba Kummerowiae Striatae 45 parts, Radix Gossampini 45 parts, Herba menyanthis 40 parts, Eriosema himalaicum Ohashi 35 parts, Cortex Ilicis Rotundae 35 parts, Fructus cinnamomi immaturus 30 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 28 parts, Lignum Dalbergiae Odoriferae 28 parts, Herba Pogostemonis 20 Fen, Fructus cydoniae oblongae 15 parts, Chalk 10 parts and Herba Asari Forbesii 5 parts.
The preparation method of described Chinese medicine composition, comprises the following steps:
(1) by Herba Limonii Gmelinii, Calyx Trapae, Radix Rumicis Patientiae, Radix Gossampini, Cortex Ilicis Rotundae, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis), Herba Pogostemonis with Fructus cydoniae oblongae puts into container, first add 10 times amount distilled water immersions after 4 hours, heated and boiled 4 hours, extract; Second time adds 8 times amount distilled water heated and boiled 2 hours, extracts; Third time adds 8 times amount distilled water heated and boiled 1 hour, extracts; Merge extractive liquid, filters, obtains filtrate for subsequent use;
(2) Folium Callicarpae Formosanae, Fructus cinnamomi immaturus, Lignum Dalbergiae Odoriferae and Chalk are ground into powder, cross 100 order fine powders, for subsequent use;
(3) Herba Kummerowiae Striatae and Herba menyanthis are smash juice, filter impurity, stays juice, for subsequent use;
(4) Eriosema himalaicum Ohashi and Herba Asari Forbesii are immersed yellow wine 3 hours, after taking-up, sun dehydration, pours in pot, and slow fire parch, after cooling, is smashed to pieces and ground into powder, crosses 120 order fine powders, for subsequent use;
(5) by the juice mixing obtained by fine powder obtained to filtrate obtained for above-mentioned steps (1), step (2) and step (4) and step (3), to obtain final product.
Model case
Wear certain, man, 3 years old, without inducement, patient occurred that laryngopharynx swelling and pain was uncomfortable before two days, start heating this morning, light watery nasal discharge, takes nimesulide granule, DeGrain, take the Chinese medicine composition of the embodiment of the present invention 3 after three days, symptom obviously alleviates, and brings down a fever, and fully recovers after continuing to take three days.Follow up a case by regular visits to after two weeks, without recurrence.
Journey, female, 6 years old, patient's heating was up to 39.3 DEG C, and red swelling of the pharynx has dense point, takes some febrifuge, burn and decorporate, but tonsil inflammation does not disappear, and takes the Chinese medicine composition of the embodiment of the present invention 3 after three days, and red swelling of the pharynx disappears, and continued to take recovery from illness after a week.Follow up a case by regular visits to after one month, without recurrence.
Tang, female, 10 years old, generates heat up to 41.3 DEG C, red swelling of the pharynx has dense point, and antiadoncus has yellow secretions, takes some febrifuge and antibiotic medicine, have no improvement, take the Chinese medicine composition of the embodiment of the present invention 3 after three days, symptom and sign are clearly better, and fully recover after continuing to take three days.Follow up a case by regular visits to after two weeks, without recurrence.
To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.
In addition, be to be understood that, although this description is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of description is only for clarity sake, those skilled in the art should by description integrally, and the technical scheme in each embodiment also through appropriately combined, can form other embodiments that it will be appreciated by those skilled in the art that.
Claims (4)
1. the application of Chinese medicine composition in preparation treatment pediatric amygdalitis medicine, it is characterized in that, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 58-82 part, Calyx Trapae 55-79 part, Radix Rumicis Patientiae 50-74 part, Folium Callicarpae Formosanae 48-72 part, Herba Kummerowiae Striatae 45-65 part, Radix Gossampini 45-65 part, Herba menyanthis 40-60 part, Eriosema himalaicum Ohashi 35-55 part, Cortex Ilicis Rotundae 35-55 part, Fructus cinnamomi immaturus 30-50 part, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 28-48 part, Lignum Dalbergiae Odoriferae 28-48 part, Herba Pogostemonis 20-40 Fen, Fructus cydoniae oblongae 15-35 part, Chalk 10-30 part and Herba Asari Forbesii 5-25 part.
2. the application of Chinese medicine composition according to claim 1 in preparation treatment pediatric amygdalitis medicine, it is characterized in that, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 76 parts, Calyx Trapae 73 parts, Radix Rumicis Patientiae 68 parts, Folium Callicarpae Formosanae 66 parts, Herba Kummerowiae Striatae 60 parts, Radix Gossampini 60 parts, Herba menyanthis 55 parts, Eriosema himalaicum Ohashi 50 parts, Cortex Ilicis Rotundae 50 parts, Fructus cinnamomi immaturus 45 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 43 parts, Lignum Dalbergiae Odoriferae 43 parts, Herba Pogostemonis 35 Fen, Fructus cydoniae oblongae 30 parts, Chalk 25 parts and Herba Asari Forbesii 20 parts.
3. the application of Chinese medicine composition according to claim 1 in preparation treatment pediatric amygdalitis medicine, it is characterized in that, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 70 parts, Calyx Trapae 67 parts, Radix Rumicis Patientiae 62 parts, Folium Callicarpae Formosanae 60 parts, Herba Kummerowiae Striatae 55 parts, Radix Gossampini 55 parts, Herba menyanthis 50 parts, Eriosema himalaicum Ohashi 45 parts, Cortex Ilicis Rotundae 45 parts, Fructus cinnamomi immaturus 40 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 38 parts, Lignum Dalbergiae Odoriferae 38 parts, Herba Pogostemonis 30 Fen, Fructus cydoniae oblongae 25 parts, Chalk 20 parts and Herba Asari Forbesii 15 parts.
4. the application of Chinese medicine composition according to claim 1 in preparation treatment pediatric amygdalitis medicine, it is characterized in that, according to parts by weight, the raw material making this drug composition active component is: Herba Limonii Gmelinii 64 parts, Calyx Trapae 61 parts, Radix Rumicis Patientiae 56 parts, Folium Callicarpae Formosanae 54 parts, Herba Kummerowiae Striatae 50 parts, Radix Gossampini 50 parts, Herba menyanthis 45 parts, Eriosema himalaicum Ohashi 40 parts, Cortex Ilicis Rotundae 40 parts, Fructus cinnamomi immaturus 35 parts, Ramulus et Folium Cotoneastri Horizontalis (Radix Cotoneastri horizontalis) 33 parts, Lignum Dalbergiae Odoriferae 33 parts, Herba Pogostemonis 25 Fen, Fructus cydoniae oblongae 20 parts, Chalk 15 parts and Herba Asari Forbesii 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510540187.9A CN104997946A (en) | 2015-08-31 | 2015-08-31 | Application of traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510540187.9A CN104997946A (en) | 2015-08-31 | 2015-08-31 | Application of traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104997946A true CN104997946A (en) | 2015-10-28 |
Family
ID=54370983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510540187.9A Withdrawn CN104997946A (en) | 2015-08-31 | 2015-08-31 | Application of traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104997946A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104983952A (en) * | 2015-07-22 | 2015-10-21 | 陈�峰 | Preparation method of traditional Chinese medicine for treating acute tonsillitis |
-
2015
- 2015-08-31 CN CN201510540187.9A patent/CN104997946A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104983952A (en) * | 2015-07-22 | 2015-10-21 | 陈�峰 | Preparation method of traditional Chinese medicine for treating acute tonsillitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103505656A (en) | Chinese medicine preparation for treating stomatitis | |
| CN103041341B (en) | Traditional Chinese medicine composition for curing tuberculous exadative pleurisy and preparation method thereof | |
| CN102309687B (en) | Medicament for treating faucitis | |
| CN103191167B (en) | Application of eupatorium Chinese | |
| CN104997946A (en) | Application of traditional Chinese medicine composition to preparation of medicine for treating child amygdalitis | |
| CN103463498B (en) | Traditional Chinese medicine preparation for treating sphagitis | |
| CN104983952A (en) | Preparation method of traditional Chinese medicine for treating acute tonsillitis | |
| CN104225405A (en) | Chinese medicinal buccal tablet for treating respiratory tract infection and preparation method | |
| CN105125639A (en) | Traditional Chinese medicine composition for preventing and treating mastitis of dairy cattle | |
| CN103961562A (en) | Concentrated oral solution for treating recurrent oral ulcer by type of fire excess from yin deficiency | |
| CN104906472A (en) | Traditional Chinese medicine composition for preventing and treating cough-variant asthma | |
| CN100409884C (en) | Chinese traditional medicine for treating cold | |
| CN105232991A (en) | Medicine composition for treating gastric mucosal lesion | |
| CN105250435A (en) | Compound Chinese herbal medicine preparation for treating influenza and preparation method of compound Chinese herbal medicine preparation | |
| CN105395879A (en) | Traditional Chinese medicine used for treating senile chronic bronchitis | |
| CN104587035A (en) | Medicine composition for treating oral ulcer and preparation method for medicine composition | |
| CN104274708A (en) | Traditional Chinese medicine for treating hyperthyroidism | |
| CN103446274B (en) | Traditional Chinese medicine oral liquid for treating infantile scarlet fever and preparation method thereof | |
| CN103877466B (en) | A kind of medicine and preparation method for the treatment of cough with copious phlegm | |
| CN104435133A (en) | Medicament for reducing fever | |
| CN104644929B (en) | Traditional Chinese medicine for treating wind-cold type acute tonsillitis caused by exogenous wind | |
| CN103230464B (en) | Dai medical mixture for treating cough | |
| CN104162077A (en) | Traditional Chinese medicine for treating infantile eczema | |
| CN102670959A (en) | Anti-influenza Chinese herba preparation and preparation method thereof | |
| CN105596986A (en) | Medicine decoction for treating anemopyretic cold and upper respiratory tract infection and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151028 |